International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia

NCT00876876 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Stopped Created Extension study - This study was no longer feasible

Conditions

Hypervolemic Hyponatremia

Interventions

DRUG: Lixivaptan

Sponsor

CardioKine Inc.

Collaborators

[object Object]
[object Object]